Safety and Efficacy of Deferasirox (ICL670) in Patients With Iron Overload Resulting From Hereditary Hemochromatosis
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
Brief Summary: This study was designed to explore a safe dose and characterize the
preliminary safety and efficacy of ICL670 in adult patients with previously documented
history of homozygous C282Y.